EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Serum Amyloid A (SAA) and Its Interaction with High-Density Lipoprotein Cholesterol (HDL-C): A Comprehensive Review

Angela P Moissl-Blanke iD, Graciela E Delgado, Bernhard K Krämer iD, Rüdiger Siekmeier, Daniel Duerschmied iD, Winfried März iD, Marcus E Kleber iD

International Journal of Molecular Sciences · 25.12.2025 · 27 (1) · 241

DOI: 10.3390/ijms27010241 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.12.2025. Verfasst von Angela P Moissl-Blanke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I (Cardiology, Angiology, Hemostaseology, Intensive Care), Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim,…. Hauptthemen laut MEDLINE: Serum Amyloid A Protein, Cholesterol, HDL, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum Amyloid A (SAA) is an acute-phase apolipoprotein that acts as both a sensitive biomarker of systemic inflammation and an active modulator of lipid metabolism and vascular homeostasis. This review summarises current insights into the interaction between SAA and high-density lipoproteins (HDL), with particular emphasis on its role in inflammation-driven cardiovascular disease (CVD). The incorporation of SAA into HDL markedly alters its composition and function. The displacement of apolipoprotein A-I impairs cholesterol efflux capacity, reduces antioxidative activity, and promotes a pro-inflammatory phenotype, transforming protective HDL into a dysfunctional particle. These changes contribute to endothelial dysfunction, foam cell formation, and atherogenesis. Elevated SAA levels are also associated with adverse cardiovascular and metabolic outcomes, including coronary artery disease, type 2 diabetes, and chronic kidney disease. Isoform-specific variations in SAA–HDL interactions are emerging as key modulators of these effects. This review also discusses emerging therapeutic and nutritional strategies to modulate the SAA–HDL axis, including anti-inflammatory therapies, HDL mimetics, and diet-based interventions. Future research should prioritise the standardisation of SAA measurement, characterisation of isoform-specific functions, and translational studies integrating SAA into cardiovascular risk stratification and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serum Amyloid A ProteinCholesterol, HDLCardiovascular DiseasesHumansAnimalsInflammation

Stichwörter der Autor:innen

HDL mimeticsSerum Amyloid A (SAA)anti-inflammatory therapycardiovascular diseasecholesterol effluxhigh-density lipoprotein (HDL)inflammationnutritional modulationoxidative stress

Substanzen

Serum Amyloid A ProteinCholesterol, HDL

Autor:innen und Institutionen

  • Department of Medicine I (Cardiology, Angiology, Hemostaseology, Intensive Care), Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
  • LURIC Study GmbH, Josef-Mörtl-Straße 23, 86482 Aystetten, Germany.
  • Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
  • Federal Institute for Drugs and Medical Services, 53175 Bonn, Germany.
  • Department of Medicine III (Cardiology, Pneumonology, Angiology), Medical Faculty Heidelberg, University of Heidelberg, 69120 Heidelberg, Germany.
  • SYNLAB Academy, SYNLAB Holding Deutschland GmbH, 68161 Mannheim, Germany.

ORCID-Profile: Angela P Moissl-Blanke, Bernhard K Krämer, Daniel Duerschmied, Winfried März, Marcus E Kleber

Zitieren

APA

Moissl-Blanke, A. P., Delgado, G. E., Krämer, B. K., Siekmeier, R., Duerschmied, D., März, W., & Kleber, M. E. (2025). Serum Amyloid A (SAA) and Its Interaction with High-Density Lipoprotein Cholesterol (HDL-C): A Comprehensive Review. International Journal of Molecular Sciences, 27(1), 241. https://doi.org/10.3390/ijms27010241

Vancouver

Moissl-Blanke AP, Delgado GE, Krämer BK, Siekmeier R, Duerschmied D, März W, et al. Serum Amyloid A (SAA) and Its Interaction with High-Density Lipoprotein Cholesterol (HDL-C): A Comprehensive Review. International Journal of Molecular Sciences. 2025;27(1):241. doi:10.3390/ijms27010241

BibTeX
@article{MoisslBlanke2025,
  author = {Moissl-Blanke, Angela P and Delgado, Graciela E and Krämer, Bernhard K and Siekmeier, Rüdiger and Duerschmied, Daniel and März, Winfried and Kleber, Marcus E},
  title = {Serum Amyloid A (SAA) and Its Interaction with High-Density Lipoprotein Cholesterol (HDL-C): A Comprehensive Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {241},
  doi = {10.3390/ijms27010241}
}
Kostenlos starten →